Pharma's future comes to London
Pharma Integrates 2012 brings together industry leaders for two days of strategic discussion
On the 28 and 29 November 2012 influential leaders in the pharma world will come together in London for Pharma Integrates 2012. The line-up of high profile speakers will include Dr Joseph DiMasi, Director Economic Analysis, Tufts Centre for the Study of Drug Development, and Tommy Dolan, VP Drug Product Design & Supply, Pfizer.
Anyone interested in the future of the pharmaceutical industry and how strategic partnerships will create growth will be at this year's must attend event.
The central questions being considered during the two-day event all revolve around future productivity, partnership opportunities, barriers to innovation and prospects in the emerging economies through collaboration.
The ability to identify and develop strong trusting partnerships will be one of the key competitive differentiators
Senior executives from across the pharmaceutical industry, such as Wes Wheeler, CEO of Marken, and Dr Peter Comes, Corporate VP End-to-End Supply Network Strategy at Boehringer Ingelheim, will lead the discussions and panel sessions. Attendees will therefore benefit from a unique opportunity to engage in truly open, interactive and thought-provoking discussion about the future of their industry.
‘The ability to identify and develop strong trusting partnerships will be one of the key competitive differentiators for any stakeholder in this industry,’ said Mark Cassidy, President API Services, Piramal Healthcare, and Chairman of Pharma Integrates 2012.
Pharma Integrates 2012 has been organised by pharmaceutical event specialists Life Sciences Index. There are a limited number of delegate places remaining, so if you are interested in attending visit www.lifesciencesindex.com or contact the organisers Christopher Watt and/or Samuel Thangiah straight away on +44 1883 332 676 for more information.